Jiangsu Zhengdan Chemical Industry Co., Ltd. (SHE:300641)
China · Delayed Price · Currency is CNY 11.81
-0.32 (-2.64%)
Nov 13, 2026, 3:04 PM CST
SHE:300641 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,936 | 2,289 | 3,480 | 1,537 | 1,924 | 1,759 |
Other Revenue | 1.16 | 1.16 | 0.18 | 0.78 | - | 0.22 |
| 1,937 | 2,291 | 3,480 | 1,538 | 1,924 | 1,759 | |
Revenue Growth | -30.29% | -34.19% | 126.31% | -20.09% | 9.38% | 33.52% |
Cost of Revenue | 1,543 | 1,431 | 2,043 | 1,479 | 1,809 | 1,563 |
Gross Profit | 394.62 | 859.85 | 1,437 | 59.17 | 115.08 | 196.07 |
Selling, General & Admin | 35.88 | 38.52 | 40.58 | 38.23 | 45.11 | 43.93 |
Research & Development | 34.82 | 20.91 | 20.59 | 22.42 | 17.07 | 20.86 |
Other Operating Expenses | 7.91 | 13.59 | 10.06 | 3.78 | 5.73 | 4.3 |
Operating Expenses | 78.59 | 70.77 | 66.81 | 67.46 | 66.19 | 68.14 |
Operating Income | 316.03 | 789.08 | 1,370 | -8.29 | 48.89 | 127.94 |
Interest Expense | - | -0.01 | -4.53 | -12.1 | -10.16 | -15.7 |
Interest & Investment Income | 43.29 | 48.41 | 20.74 | 22.22 | 5.97 | 10.62 |
Currency Exchange Gain (Loss) | -5.36 | -5.36 | 14.81 | 8.3 | 20.42 | -5.5 |
Other Non Operating Income (Expenses) | -27.74 | -0.23 | -0.37 | -0.21 | -0.49 | -0.33 |
EBT Excluding Unusual Items | 326.23 | 831.89 | 1,401 | 9.93 | 64.63 | 117.02 |
Gain (Loss) on Sale of Investments | 14.78 | 1.19 | - | - | 0.45 | 0.73 |
Gain (Loss) on Sale of Assets | -0.27 | 0 | -0.01 | - | - | - |
Asset Writedown | 8.5 | -0.02 | -5.19 | -4.29 | -1.44 | -0.04 |
Other Unusual Items | 2.27 | 2.41 | 0.87 | 3.48 | 1.53 | 3.36 |
Pretax Income | 351.51 | 835.47 | 1,397 | 9.12 | 65.17 | 121.07 |
Income Tax Expense | 44.4 | 121.37 | 206.88 | -0.75 | 9.33 | 16.59 |
Earnings From Continuing Operations | 307.11 | 714.1 | 1,190 | 9.88 | 55.83 | 104.48 |
Minority Interest in Earnings | -0.34 | 0.04 | 0.01 | - | - | - |
Net Income | 306.78 | 714.14 | 1,190 | 9.88 | 55.83 | 104.48 |
Net Income to Common | 306.78 | 714.14 | 1,190 | 9.88 | 55.83 | 104.48 |
Net Income Growth | -70.50% | -39.98% | 11949.39% | -82.31% | -46.56% | 142.99% |
Shares Outstanding (Basic) | 526 | 525 | 506 | 494 | 508 | 498 |
Shares Outstanding (Diluted) | 526 | 525 | 509 | 494 | 508 | 498 |
Shares Change | -1.03% | 3.26% | 2.99% | -2.73% | 2.02% | 4.14% |
EPS (Basic) | 0.58 | 1.36 | 2.35 | 0.02 | 0.11 | 0.21 |
EPS (Diluted) | 0.58 | 1.36 | 2.34 | 0.02 | 0.11 | 0.21 |
EPS Growth | -70.19% | -41.88% | 11600.00% | -81.82% | -47.62% | 133.33% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 256.47 | 1,044 | 792.34 | 102.17 | 50.98 | 40.99 |
Free Cash Flow Per Share | 0.49 | 1.99 | 1.56 | 0.21 | 0.10 | 0.08 |
Dividend Per Share | 0.500 | 0.800 | 0.700 | 0.020 | 0.050 | 0.050 |
Dividend Growth | -16.67% | 14.29% | 3400.00% | -60.00% | 0% | 150.00% |
Gross Margin | 20.37% | 37.54% | 41.30% | 3.85% | 5.98% | 11.14% |
Operating Margin | 16.31% | 34.45% | 39.38% | -0.54% | 2.54% | 7.27% |
Profit Margin | 15.84% | 31.18% | 34.19% | 0.64% | 2.90% | 5.94% |
Free Cash Flow Margin | 13.24% | 45.57% | 22.77% | 6.64% | 2.65% | 2.33% |
EBITDA | 383.52 | 856.12 | 1,437 | 61.18 | 110.33 | 187.1 |
EBITDA Margin | 19.80% | 37.38% | 41.29% | 3.98% | 5.73% | 10.63% |
D&A For EBITDA | 67.49 | 67.04 | 66.44 | 69.47 | 61.44 | 59.17 |
EBIT | 316.03 | 789.08 | 1,370 | -8.29 | 48.89 | 127.94 |
EBIT Margin | 16.31% | 34.45% | 39.38% | -0.54% | 2.54% | 7.27% |
Effective Tax Rate | 12.63% | 14.53% | 14.81% | - | 14.32% | 13.71% |
Revenue as Reported | 1,937 | 2,291 | 3,480 | 1,538 | 1,924 | 1,759 |